Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
N05CM08
|
| gptkbp:brand |
gptkb:Karbromian
|
| gptkbp:CASNumber |
156-10-5
|
| gptkbp:containsElement |
carbon
hydrogen nitrogen oxygen bromine |
| gptkbp:discoveredIn |
1960s
|
| gptkbp:drugClass |
sedative
hypnotic |
| gptkbp:hasMolecularFormula |
C9H11BrN2O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
Karbromian
|
| gptkbp:IUPACName |
5-bromo-3-(2-methylpropyl)-1,2,4-oxadiazole
|
| gptkbp:legalStatus |
prescription only (Poland)
|
| gptkbp:marketedIn |
gptkb:Poland
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache drowsiness |
| gptkbp:usedAs |
sleep aid
benzodiazepine |
| gptkbp:bfsParent |
gptkb:Kanjar_Ro
|
| gptkbp:bfsLayer |
6
|